Your oncologist needs to know the extent (stage) of non-Hodgkin lymphoma to plan the best treatment. Staging is a careful attempt to determine whether the cancer cells have moved to other areas of the body. And if they have, how extensively have they spread?
Lymphoma usually starts in a lymph node. Because of this, the cancer cells can spread to nearly any other part of the body rather easily. Some of the most common areas it can spread include the liver, lungs, bone, and bone marrow.
After a diagnosis of non-Hodgkin lymphoma, the hematologist will need to find out if it’s spread beyond the area where it started. There may be one or more of the following necessary:
Staging is a method to determine how far cancer has spread in the body based on the location of the lymphoma cells in organs or tissues and the number of areas affected. The stage and other factors help doctors determine the most effective cancer treatment.
The Lugano classification system, which replaced the older Ann Arbor system, is currently used for staging lymphoma. The stages of non-Hodgkin lymphoma are classified as Roman numerals I, II, III, or IV (1 through 4), depending on the extent of tumor spread. In contrast to other cancers, a stage IV lymphoma diagnosis doesn’t indicate how well or poorly the patient will respond to treatment but rather the specific location of the disease. Even though stage IV lymphomas are the most advanced, they can still be treated successfully.
Either of these conditions applies:
Either of these conditions applies:
There is lymphoma in lymph nodes on both sides of the diaphragm (stage III), or the cancer has spread to various areas of one or more organs or tissues and the lymph nodes. Lymphoma may be found in the liver, blood, or bone marrow. (stage IV). Stage III-IV lymphomas are common, treatable, and often curable, depending on the NHL subtype. Stage III and IV are now considered a single category; therefore, they have the same treatment and prognosis.
Progressive disease or refractory NHL refers to cancer that grows larger or spreads while the patient is undergoing treatment for the original lymphoma.
Cancer that comes back after treatment is referred to as recurrent cancer. Recurrent cancer could either return to the area where it first started or somewhere else in the body. There may be times when recurrent lymphoma needs to be re-staged using the system above.
Part of the staging process for non-Hodgkin lymphoma includes an assessment of the patient’s prognosis or most likely outcome. The Eastern Cooperative Oncology Group (ECOG) Performance Status is a common scale based on how well the patient can carry out daily activities. After an assessment, the results are graded based on a functional assessment scale.
The (ECOG) Performance Status grades are as follows:
A lower score means the patient has a better prognosis. Typically, the better someone can walk and care for themselves, the better the prognosis.
Your lymphoma doctor, who is a hematologist/oncologist, will recommend a treatment plan most likely to be effective based on your NHL stage and overall prognosis.
Learn about the treatment options available for non-Hodgkin lymphoma.